Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Neurobiological brain disorder Stories

2012-03-19 23:02:33

Attorney Thomas Henson Jr. recently contributed a chapter for the book The Miracle Mind: Sonya´s Story, a guidebook designed to help stroke and traumatic brain injury (TBI) patients, their families, and their caregivers. RALEIGH, North Carolina (PRWEB) March 19, 2012 North Carolina attorney Thomas Henson Jr. recently contributed a chapter for the book The Miracle Mind: Sonya´s Story, a guidebook designed to help stroke and traumatic brain injury (TBI) patients, their families, and...

2012-03-19 15:48:41

Researchers looked at disease progression in people who did and did not consume alcohol, wine, coffee and fish Patients with relapsing onset Multiple Sclerosis (MS) who consumed alcohol, wine, coffee and fish on a regular basis took four to seven years longer to reach the point where they needed a walking aid than people who never consumed them. However the study, published in the April issue of the European Journal of Neurology, did not observe the same patterns in patients with...

2012-03-16 05:44:20

(Ivanhoe Newswire) — Look into your brain! A new study reveals people with mild vascular disease are more likely to have problems with memory skills and thinking. Damage to the retina is called retinopathy. Researchers found people with mild vascular disease with retinopathy are more likely to have problems with thinking and memory skills because they may also have vascular disease in the brain. In the study, the damage was mild enough to not cause significant symptoms. The study...

2012-03-14 06:30:00

LONDON, March 14, 2012 /PRNewswire/ -- Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis (MS) market. This is being exacerbated by the limited availability of accurate diagnostic tools. There is, therefore, an immediate need for innovative and enhanced therapeutic and diagnostic tools that support improved diagnosis and expand the range of treatment options. New analysis from Frost & Sullivan...

2012-03-14 05:30:00

ANN ARBOR, Mich., March 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today that patient enrollment has been completed in a Phase II clinical trial evaluating the efficacy and safety of Synthetic Biologics' proprietary oral formulation of estriol (Trimesta(TM)) for the treatment of relapsing-remitting multiple sclerosis (MS). With over $8 million...

2012-03-09 12:30:00

Commemorating Brain Injury Awareness Month 2012, TBI survivor, Jason Deierlein, has created series of videos featuring cognitive and neurological experts like Dr. Matthew Antonucci, DC, DACNB. Learn six important factors to keep your brain healthy. Charleston, SC (PRWEB) March 09, 2012 March 2012 is brain injury awareness month in North America. Jason Deierlein, traumatic brain injury and coma survivor, has created a place online for other TBI Survivors called "My Positive Perspective"....

2012-03-06 11:00:23

Researchers at the Perelman School of Medicine at the University of Pennsylvania have demonstrated that aggressive treatment of severe traumatic brain injury, which includes invasive monitoring of intracranial pressure (ICP) and decompressive craniectomy, produces better patient outcomes than less aggressive measures and is cost-effective in patients no matter their age——even in patients 80 years of age. These important findings can be found in the article "Is aggressive treatment...

2012-03-02 12:14:00

CHERRY HILL, N.J., March 2, 2012 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to recognize March as MS Awareness Month. During the month of March, MSAA will be highlighting various programs designed to expand knowledge, understanding, and support of individuals whose lives are affected by multiple sclerosis (MS). Such program offerings include: (Logo: http://photos.prnewswire.com/prnh/20110615/PH20696LOGO ) Joining the 50,000 individuals who have...

2012-02-21 06:05:09

(Ivanhoe Newswire) -- A new study performed on rats shows promise in helping fight against the harmful effects of traumatic brain injury. Traumatic brain injury causes a decrease in blood flow in the cerebrum of the brain.  If blood flow is prolonged, it could lead to death or permanent cell dysfunction.  The endothelin receptor A (ETrA), a receptor in the brain, contributes to the decrease of blood flow as early as four hours after the injury on the brain occurs.  A new...

2012-02-19 16:15:00

NEW ORLEANS, Feb. 19, 2012 /PRNewswire-USNewswire/ -- A new drug is showing promise in shielding against the harmful effects of traumatic brain injury (TBI) in rats, according to a study that was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. "There are currently no primary treatments for TBI, so this research provides hope that effective treatments can be developed," said study author Michael...